EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Net Shares Issued and Repurchased (2012 - 2026)

Analysis

EyePoint (EYPT) Net Shares Issued and Repurchased (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.47 Mn
Dec 31, 2025 2.92 Mn
Mar 31, 2025 2.14 Mn
Dec 31, 2024 2.49 Mn
Mar 31, 2024 1.71 Mn
Dec 31, 2023 2.92 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 1.87 Mn
Mar 31, 2022 1.47 Mn
Dec 31, 2021 1.31 Mn
Mar 31, 2021 120,427.00
Dec 31, 2020 415,339.00
Mar 31, 2020 3.61 Mn
Dec 31, 2019 5.51 Mn
Sep 30, 2018 485,000.00
Jun 30, 2018 100,000.00
Sep 30, 2017 1.16 Mn
Jun 30, 2017 850,000.00
Mar 31, 2017 182,700.00
Sep 30, 2016 1.11 Mn